Summit Therapeutics May Have Further Upside From Here

Dr_Microbe Summit Therapeutics (NASDAQ:SMMT) will release its latest earnings on 6 August, while the company also has trial data released in September. This could be the catalyst for further upside. Summit to release second-quarter earnings Summit Therapeutics will release its second-quarter earnings and operational update on 6 August. In its first-quarter earnings, Summit reported progress on its work with Ivonescimab (SMT112), a "potentially first-in-class antibody combining the effects of immunotherapy v ...